Side Effects of sulconazole topical: A Synthesis of Findings from 2 Studies

  1. Home
  2. Side Effects of sulconazole topical
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of sulconazole topical: A Synthesis of Findings from 2 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of sulconazole topical: A Synthesis of Findings from 2 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

One study found that terconazole, a broad-spectrum triazole antifungal, was effective in treating vaginal candidiasis in rats. 2 Terconazole was superior to other antifungal agents in treating vaginal candidiasis and had a long-acting therapeutic effect. The study also reported no side effects were observed at any concentration of terconazole.

Reasons for Side Effects

The provided research data does not offer information about the reasons for side effects associated with sulconazole topical.

Common Side Effects

The provided research data does not offer information about common side effects associated with sulconazole topical.

Side Effects Management

The provided research data does not offer information about side effects management associated with sulconazole topical.

Comparison Between Studies

Similarities in Studies

Both studies focused on evaluating the effectiveness of different medications: one study examined the effectiveness of terconazole in treating vaginal candidiasis in rats, while the other investigated the potential interactions between mirabegron or tamsulosin and other medications.

Differences in Studies

The study on terconazole 2 focused on the effectiveness of terconazole in treating vaginal candidiasis in rats. The study on mirabegron and tamsulosin 1 evaluated the potential interactions between these medications and other cardiovascular medications.

Points to Note for Application in Real Life

While the study on terconazole 2 suggests its effectiveness in treating vaginal candidiasis in rats, further research is needed to confirm its safety and efficacy in humans. It is important to consult with a healthcare professional before using any medication, including terconazole.

Limitations of Current Research

The information on sulconazole topical side effects is limited in the provided research data. Further research is needed to evaluate the common side effects and their management for this medication.

Future Research Directions

More research is needed to thoroughly investigate the potential side effects of sulconazole topical and develop appropriate strategies for their management.

Conclusion

While the research suggests terconazole's potential effectiveness in treating vaginal candidiasis in rats, more research is needed to confirm its safety and efficacy in humans. The information about sulconazole topical side effects is limited, and further research is crucial for a comprehensive understanding of its potential side effects and their management.

Literature analysis of 2 papers
Positive Content
2
Neutral Content
0
Negative Content
0
Article Type
1
0
0
0
2
1.

Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men.

Author: van GelderenMarcel, TretterReiner, MeijerJohn, DorrepaalCaroline, Gangaram-PandayShanti, BrooksAshley, KrauwinkelWalter, DickinsonJames

No clinically relevant changes

Co-treatment with tamsulosin and mirabegron did not result in clinically relevant changes in cardiovascular safety.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

2.

The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.

Author: Van CutsemJ

Treats vaginal candidiasis

Terconazole, a broad-spectrum triazole antifungal, was effective against Candida species and Trichosporon beigelii in vitro and in vivo.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.